Arlington Financial Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330K | Hold |
615
| – | – | 0.05% | 71 |
|
|
2025
Q1 | $258K | Buy |
615
+65
| +12% | +$27.3K | 0.05% | 98 |
|
|
2024
Q4 | $227K | Sell |
550
-211
| -28% | -$87.2K | 0.05% | 88 |
|
|
2024
Q3 | $384K | Hold |
761
| – | – | 0.08% | 56 |
|
|
2024
Q2 | $371K | Sell |
761
-45
| -6% | -$21.9K | 0.08% | 58 |
|
|
2024
Q1 | $435K | Hold |
806
| – | – | 0.1% | 57 |
|
|
2023
Q4 | $447K | Hold |
806
| – | – | 0.13% | 63 |
|
|
2023
Q3 | $352K | Hold |
806
| – | – | 0.12% | 52 |
|
|
2023
Q2 | $405K | Hold |
806
| – | – | 0.15% | 46 |
|
|
2023
Q1 | $403K | Buy |
806
+245
| +44% | +$123K | 0.16% | 47 |
|
|
2022
Q4 | $229K | Buy |
+561
| New | +$229K | 0.1% | 59 |
|
|
2022
Q1 | – | Sell |
-311
| Closed | -$205K | – | 66 |
|
|
2021
Q4 | $205K | Buy |
+311
| New | +$205K | 0.07% | 74 |
|